Literature DB >> 9623438

Changes in right atrial catecholamine content in naïve rats and after naloxone-induced withdrawal.

J V Rabadán1, M V Milanés, M L Laorden.   

Abstract

In this study, we determined if changes in heart catecholamine content during naloxone-induced withdrawal correlated with modifications in heart rate. In addition, we determined plasma concentrations of corticosterone as an index of the hypothalamo-pituitary-adrenal (HPA) axis. The effects of naloxone on norepinephrine, epinephrine or dopamine content and turnover, plasma concentrations of corticosterone and the mechanical response of the right atria of the rat were studied. Male rats were implanted with placebo or morphine pellets for 7 days. On the day of sacrifice, animals were injected with saline or naloxone 1 mg kg-1 s.c. to precipitate a withdrawal syndrome. Administration of naloxone to morphine-treated (tolerant) animals induced a decrease in atrial content of norepinephrine, epinephrine and dopamine (290.2 (11.9) ng g-1, 15.6 (2.1) ng g-1 and 9.52 (0.5) ng g-1, respectively) and an increase (1.38 (0.2) ng g-1 in the dihydroxy phenyl acetic acid/dopamine (DOPAC/DA) ratio. Administration of naloxone to morphine-treated animals enhanced plasma concentrations of corticosterone (435.8 (27.6) ng ml-1). In the isolated right atria, L-naloxone induced an increase in atrial rate in preparations from morphine-treated rats whereas in placebo-pelleted (naïve) rats, L-naloxone induced a decrease. In contrast, administration of D-naloxone (inactive isomer) produced a decrease in atrial rate in preparations from placebo or morphine-treated rats. We conclude that this study has provided evidence that naloxone-induced withdrawal was characterized by activation of catecholaminergic neurones in the heart that was accompanied by an increase in atrial rate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9623438     DOI: 10.1093/bja/80.3.354

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  6 in total

1.  Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.

Authors:  Pilar Almela; Manuela Cerezo; A González-Cuello; M Victoria Milanés; M Luisa Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-11-25       Impact factor: 3.000

2.  Activation of c-fos expression in the heart after morphine but not U-50,488H withdrawal.

Authors:  Ana González-Cuello; M Victoria Milanés; M Teresa Castells; M Luisa Laorden
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

3.  Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors.

Authors:  Ana González-Cuello; M Victoria Milanés; Manuel Aviles; M Luisa Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-13       Impact factor: 3.000

4.  The PKs PKA and ERK 1/2 are involved in phosphorylation of TH at Serine 40 and 31 during morphine withdrawal in rat hearts.

Authors:  P Almela; Mv Milanés; Ml Laorden
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

5.  Role of PKC in regulation of Fos and TH expression after naloxone induced morphine withdrawal in the heart.

Authors:  Pilar Almela; Manuela Cerezo; M Victoria Milanés; M Luisa Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-11       Impact factor: 3.000

6.  Crosstalk between G protein-coupled receptors (GPCRs) and tyrosine kinase receptor (TXR) in the heart after morphine withdrawal.

Authors:  Pilar Almela; Juan-Antonio García-Carmona; Elena Martínez-Laorden; María-Victoria Milanés; María-Luisa Laorden
Journal:  Front Pharmacol       Date:  2013-12-27       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.